HMN-176|173529-10-7|Acesobio Supply

Favorite | Set Home

Products > Others > > HMN-176

Product name : HMN-176

Item : c2401

Price : 200mg, $950;500mg, $1695; 1g, $2490; 2g, $3590

contact : Send inquiry to: info@acesobio.com

CAS : 173529-10-7

Molecular Weight : 382.43

Formula : C20H18N2O4S

Storage : at -20°C

Additional information : We offer significant discount for bulky quantity order.

Enlarge Image

Back

←[Previous Product] [Next Product]→

Details:

Description of:HMN-176(cas:173529-10-7)
HMN-176 is an active metabolite of the synthetic antitumor compound HMN-214.
HMN-176 (2.5 μM) greatly increases the duration of mitosis in hTERT-RPE1 and CFPAC-1 Cell lines. The effect of HMN-176 on spindle morphology does not appear to be related to effects on microtubule polymerization. HMN-176 (2.5, 0.25, and 0.025 μM) inhibits aster formation in a concentration dependent manner[1]. HMN-176 (0.1, 1.0, or 10.0 µg/mL) demonstrates inhibitory effects in multiple tumors, with notable activity seen in breast, nonsmall-cell lung, and ovarian cancer specimens. HMN-176 demonstrates activity towards 63% of the breast (5/8), 67% of the non-small cell lung (4/6), and 57% of the ovarian (4/7) tumor specimens treated with 10.0 µg/mL[2]. HMN-176 shows potent cytotoxicity, with a mean IC50 value of 118 nM. HMN-176 displays similar cytotoxicity against tumors with various characteristics from different organs[3]. Treatment with 3 μM HMN-176 suppresses the expression of MDR1 mRNA by 56%. HMN-176 has no significant effect on the residual promoter activity.

Quality control data:
Quality control by 1H-NMR, 13C-NMR, HPLC and LCMS.

REFERENCES

[1]. DiMaio MA, et al. The small organic compound HMN-176 delays satisfaction of the spindle assembly checkpoint by inhibiting centrosome-dependent microtubule nucleation. Mol Cancer Ther. 2009 Mar;8(3):592-601.
[2]. Medina-Gundrum L, et al. Investigation of HMN-176 anticancer activity in human tumor specimens in vitro and the effects of HMN-176 on differential gene expression. Invest New Drugs. 2005 Jan;23(1):3-9.
[3]. Takagi M, et al. In vivo antitumor activity of a novel sulfonamide, HMN-214, against human tumor xenografts in mice and the spectrum of cytotoxicity of its active metabolite, HMN-176. Invest New Drugs. 2003 Nov;21(4):387-99.
[4]. Tanaka H, et al. HMN-176, an active metabolite of the synthetic antitumor agent HMN-214, restores chemosensitivity to multidrug-resistant cells by targeting the transcription factor NF-Y. Cancer Res. 2003 Oct 15;63(20):6942-7.
[5]. Garland LL, et al. A phase I pharmacokinetic study of HMN-214, a novel oral stilbene derivative with polo-like kinase-1-interacting properties, in patients with advanced solid tumors. Clin Cancer Res. 2006 Sep 1;12(17):5182-9.

Related Products :

RSL3
Price: 200mg, $1250;500mg, $2090; 1g, $2995; 2g, $4395

PF 670462
Price: 200mg, $950;500mg, $1595; 1g $2390; 2g, $3590

GJ-103
Price: 200mg, $750;500mg, $1290; 1g, $1990; 2g, $2995

Netobimin
Price: 200mg, $659;500mg, $1050; 1g $1595; 2g, $2355

Tirofiban (Aggrastat)
Price: 200mg, $659;500mg, $1050; 1g $1595; 2g, $2355

GSK 1210151A (I-BET151)
Price: 200mg, $750;500mg, $1190; 1g $1890; 2g, $2995

HMN-154
Price: 200mg, $950;500mg, $1695; 1g, $2490; 2g, $3590

LY 2886721
Price: 200mg, $659;500mg, $1050; 1g $1595; 2g, $2355